Teletherapy Alone Insufficient for Mental Health Access Issues

Behavioral health care remains stagnant in its advancement, leaving countless patients to struggle without help. Cardiology, orthopedics, endocrinology, and other specialties have embraced emerging technology, leading to improved patient outcomes.

However, mental health care relies heavily on traditional methods like therapy and medication, which often do not meet the diverse needs of patients. A significant barrier to progress is the lack of support from health plans for innovative treatments.

The Department of Health and Human Services supports establishing new payment pathways to increase utilization of emerging mental health treatments. FDA-approved digital therapeutics for anxiety, PTSD, and depression, as well as biofeedback wearables, are demonstrating measurable improvements in patient outcomes and engagement.

These clinically validated tools offer comparable, if not superior, results compared to traditional therapies, with improved adherence due to their convenience. Innovative payors are beginning to adopt these technologies, but many lives could be positively impacted if more health plans prioritize these new approaches.

Current behavioral health treatment models primarily consist of talk therapy and medication, which do not fully address the needs of modern patients. New technologies can enhance care by providing continuous support outside of clinical settings, empowering patients to participate actively in their healthcare.

The integration of these devices into broader care plans can provide clinicians with new data to improve treatment adherence and patient engagement. However, outdated insurance policies remain a significant barrier.

While heart monitors are routinely covered, devices that address mental health issues are often not recognized as legitimate clinical tools. The effectiveness of these devices is well-documented, with data showing exceptional outcomes in patient satisfaction and engagement.

The report highlights that 60% of individuals suffering from anxiety disorders do not seek professional help, indicating a need for innovative health plan coverage that recognizes mental health devices.

Expanding reimbursement for these tools could bridge the gap in access to care, potentially preventing crises for patients waiting months for treatment. According to Joseph Perekupka, CEO of Freespira, the need for parity in reimbursing mental health devices is critical for advancing support for members and integrating these solutions into standard care pathways.